Snowden Capital Advisors LLC Abiomed Inc Transaction History

Snowden Capital Advisors LLC

$3.29 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$242.49 - $301.46 $1,212 - $1,507	5 Added 0.29%	1,725 $423,000
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $2,472 - $3,725	11 Added 0.64%	1,720 $425,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $280,022 - $369,952	1,010 Added 144.49%	1,709 $566,000
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $210,140 - $259,573	699 New	699 $251,000
Q3 2021 Feb 05, 2024	BUY	$310.19 - $376.2 $225,197 - $273,121	726 New	726 $236 Million
Q2 2021 Jan 08, 2024	SELL	$262.71 - $351.17 $453,962 - $606,821	-1,728 Reduced 51.4%	1,634 $510 Million
Q1 2021 Jan 08, 2024	SELL	$285.92 - $355.13 $80,915 - $100,501	-283 Reduced 7.76%	3,362 $1.07 Billion
Q4 2020 Jan 08, 2024	BUY	$251.88 - $324.2 $755 - $972	3 Added 0.08%	3,645 $1.18 Billion
Q3 2020 Jan 08, 2024	SELL	$255.22 - $317.0 $22,459 - $27,896	-88 Reduced 2.36%	3,642 $1.01 Billion
Q2 2020 Jan 08, 2024	SELL	$141.4 - $257.09 $362,973 - $659,950	-2,567 Reduced 40.77%	3,730 $901 Million
Q1 2020 Jan 08, 2024	SELL	$130.51 - $196.01 $89,399 - $134,266	-685 Reduced 9.81%	6,297 $914 Million
Q4 2019 Jan 30, 2024	SELL	$159.31 - $223.54 $673,721 - $945,350	-4,229 Reduced 37.72%	6,982 $1.19 Billion
Q4 2019 Jan 08, 2024	SELL	$159.31 - $223.54 $673,721 - $945,350	-4,229 Reduced 37.72%	6,982 $1.19 Billion
Q3 2019 Jan 30, 2024	BUY	$175.89 - $279.23 $11,608 - $18,429	66 Added 0.59%	11,211 $1.99 Billion
Q3 2019 Jan 08, 2024	SELL	$175.89 - $279.23 $2.97 Million - $4.71 Million	-16,868 Reduced 60.07%	11,211 $1.99 Billion
Q2 2019 Jan 30, 2024	BUY	$250.96 - $284.94 $2.8 Million - $3.18 Million	11,145 New	11,145 $2.9 Billion
Q2 2019 Jan 08, 2024	BUY	$250.96 - $284.94 $4.26 Million - $4.84 Million	16,994 Added 153.31%	28,079 $2.9 Billion
Q1 2019 Jan 08, 2024	SELL	$276.39 - $362.25 $3.12 Million - $4.08 Million	-11,272 Reduced 50.42%	11,085 $3.17 Billion
Q4 2018 Jan 08, 2024	SELL	$281.08 - $444.25 $157,966 - $249,668	-562 Reduced 2.45%	22,357 $7.27 Billion
Q3 2018 Jan 08, 2024	BUY	$354.53 - $449.75 $13,826 - $17,540	39 Added 0.17%	22,919 $10.3 Billion
Q2 2018 Jan 08, 2024	BUY	$278.07 - $446.21 $6.36 Million - $10.2 Million	22,880 New	22,880 $9.36 Billion
Q1 2018 Jan 08, 2024	SELL	$192.49 - $295.85 $4.4 Million - $6.76 Million	-22,855 Closed	0 $0
Q4 2017 Jan 08, 2024	BUY	$168.78 - $199.74 $3,038 - $3,595	18 Added 0.08%	22,855 $4.28 Billion
Q3 2017 Jan 08, 2024	BUY	$145.39 - $168.6 $13,521 - $15,679	93 Added 0.41%	22,837 $3.85 Billion
Q2 2017 Jan 08, 2024	BUY	N/A	2,705 Added 13.5%	22,744 $3.26 Billion
Q1 2017 Jan 08, 2024	BUY	N/A	10,331 Added 106.42%	20,039 $2.51 Billion
Q4 2016 Jan 08, 2024	BUY	N/A	157 Added 1.64%	9,708 $1.09 Billion
Q3 2016 Jan 08, 2024	SELL	N/A	-177 Reduced 1.82%	9,551 $1.23 Billion
Q2 2016 Jan 08, 2024	BUY	N/A	9,728	9,728 $1.06 Billion

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account